THE USE OF NORETHISTERONE TO SUPPRESS MENSTRUATION IN THE INTELLECTUALLY SEVERELY RETARDED WOMAN

@article{Roxburgh1973THEUO,
  title={THE USE OF NORETHISTERONE TO SUPPRESS MENSTRUATION IN THE INTELLECTUALLY SEVERELY RETARDED WOMAN},
  author={D. R. Roxburgh and Malcolm J. West},
  journal={Medical Journal of Australia},
  year={1973},
  volume={2}
}
Norethisterone (Primolut‐N) in an oral dose of 5 mg daily was given to 118 intellectually retarded women for periods of two to 30 months. A retrospective study showed that this dose of norethisterone was effective in producing amenorrhoea in 86% of the women. In those women (14%) in whom bleeding cccurred, it tended to recur at intervals of one to two months. In general, the bleeding was no more than that in a normal period. However, in three patients the bleeding, because of its severity or… Expand
Menstruation: choosing whether...and when.
TLDR
Women who may derive particular benefit from reduced menstrual frequency include not only those with medical conditions directly caused or aggravated by menses, but also those serving in the military, female athletes, mentally-retarded women with menstrual hygiene problems, young teens, and perimenopausal women. Expand
Gynecological problems of mentally retarded women
TLDR
Therapeutic amenorrhea exhibited a clinical picture of depressed pituitary gonadal axis, and among the mentally retarded cases than non‐mentally retarded controls, contraception was 58 times less (p<0.05), not smoking 1.2 times (p <0.001), the incidence of genital infections 2.9 times and tumors of all kind 4.6 times less common (p.<0.01). Expand
The legal trends—implications for menstruation/ fertility management for young women who have an intellectual disability
Since 1988, there have been a number of Family Court of Australia cases where permission was sought for a hysterectomy (surgical removal of the uterus) to be performed on premenarchal women who haveExpand
What is the desired menstrual frequency of women without menstruation-related symptoms?
TLDR
Over 50% of women without menstruation-related symptoms would like to lessen the frequency of menstrual periods and about50% of them would desire amenorrhea. Expand
Menstrual Support for Females with Developmental Disabilities: Survey and Interview of Parents or Caretakers
Menstruation is a difficult topic to address with as females with or without disabilities. It is a more significant challenge for females with developmental disabilities (DD) because it stimulates aExpand
Current evidence for the identification and management of premenstrual syndrome in women with intellectual disabilities: a systematic review
Purpose Intellectual disability (ID) is prevalent in 1 per cent of the population. Premenstrual syndrome (PMS) affects up to 5 per cent of the general population of adult women. Identification ofExpand
MENSTRUAL MANAGEMENT: THE MOTHER'S PERSPECTIVE
It is suggested in the service provision literature for people who have a learning disability (LD) that menstrual management should be addressed proactively on the basis of least restrictiveExpand
Menstrual management and women who have intellectual disabilities: Service providers and decision-making
As part of a study about menstrual management decision-making for women who have an intellectual disability and high support needs, 63 service providers were interviewed using a semi-structuredExpand
Simulation procedures for teaching independent menstrual care to mentally retarded persons.
TLDR
Four mentally retarded adolescent females participated in a program for assessment and training of independent menstrual care skills, and follow-up assessments indicated maintenance of skills for periods up to 30 weeks following termination of training. Expand

References

SHOWING 1-10 OF 27 REFERENCES
Delay of menstruation with norethindrone, an orally given progestational compound.
TLDR
Data have been gathered which indicate that administration of 20-40 mg. Expand
Continuous norethindrone, 0.35 mg., as an oral contraceptive agent.
  • J. Board
  • Medicine
  • American journal of obstetrics and gynecology
  • 1971
TLDR
There was no significant difference in oral glucose tolerance tests done in 18 women before and after taking norethindrone for 6+ months, and other serum determinations showed a significant rise in alkaline phosphatase and albumin along with a significant decrease in SGOT. Expand
Artificial induction of hypo-oestrogenic amenorrhea with methylestrenolone, or with lynestrenol.
  • J. Ferin
  • Medicine
  • Acta endocrinologica
  • 1962
TLDR
This therapeutic hypoestrogenic amenorrhea seems highly beneficial to patients suffering from various gynecological disorders especially endometriosis and idiopathic menorrhagia with chronic iron deficiency. Expand
The effect of norethindrone with and without estrogen on serum immunoreactive luteinizing hormone secretion.
TLDR
Continuous daily therapy with low-dosage norethindrone and possibly progesterone are capable of suppressing luteinizing hormone production and/or release. Expand
Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol.
TLDR
The mini pill results suggest that progesterone may be responsible for depression of adrenocortical acitivity during the luteal phase, and rise in plasma cortisol concentration probably occurred because of a corresponding rise in corticosteroid-binding globulin concentration induced by the estrogen. Expand
Pituitary and ovarian function in women on continuous low dose progestogens; effect of chlormadinone acetate and norethisterone.
TLDR
Data indicate that continuous administration of low dose CAP interferes only slightly with estrogen excretion but has a marked effect on the midcycle LH peak, which is similar to that found in the NET patients. Expand
Thyroid function studies in different phases of the menstrual cycle and in women receiving norethindrone with and without estrogen.
TLDR
Subjects receiving the continuous low-dosage norethindrone showed virtually no change in protein binding of thyroxine but did show a statistically significant decrease in serum free thyroxin levels when results during therapy were compared to results obtained during the normal menstrual cycle. Expand
Evaluation of the carcinogenic potential of the sex steroids , 1 st International Planned Parenthood Federation
  • 1972
Evaluation of the carcinogenic potential of the sex steroids, 1st International Planned Parenthood Federation. South-East Asia and Oceania Regional Medical and Scientific Congress
  • 1972
Oral contraceptives and thromboembolism, 1st International Planned Parenthood Federation
  • 1972
...
1
2
3
...